Vaximm.com - SEO Checker

Sign up for free! PDF Export
Overview of the SEO Check
Meta information
97% 
Page quality
63% 
Page structure
79% 
Link structure
90% 
Server
72% 
External factors
100% 
SEO Score
Response time
0.85 s
File size
649.90 kB
Words
439
Media files
11
Number of links
37 internal / 19 external

Task list of SEO Improvements

Meta specifications

Title
(Critically important)
Developing oral T-cell immunotherapies against cancer
The length of the page title is perfect. (491 pixels out of 580 max pixel length)
There are no duplicate words in the title
Meta description
(Critically important)
VAXIMM is developing oral T-cell immunotherapies
The length of the meta description is perfect. (315 pixels out of 1000 max pixel length)
Crawlability
(Critically important)
There are no problems in accessing the website.
Canonical URL
(Important)
https://vaximm.com/
There is a valid canonical link specified.
Language
(Somewhat important)
Language detected in text: en
Language defined in HTML: en-us
Server location: United States of America
The following language is defined by HTML: en-us
Alternate/Hreflang Links
(Somewhat important)
Language for link pointing to page itself inaccurate
Other meta tags
(Somewhat important)
There is no rel next meta tag on this page.
There is no rel prev meta tag on this page.
Domain
(Somewhat important)
The domain is no subdomain.
The domain length is good.
The domain does not contain non-latin characters.
Page URL
(Somewhat important)
No parameters were found in the URL.
No session ID was found in the URL.
The URL does not have too many subdirectories.
Charset encoding
(Somewhat important)
The charset encoding (UTF-8) is set correctly.
Doctype
(Nice to have)
The doctype HTML 5 is set correctly.
The doctype is placed at first in the HTML code.
Favicon
(Nice to have)
The favicon is linked correctly.

Meta tags

NameValue
viewportwidth=device-width, initial-scale=1.0
descriptionVAXIMM is developing oral T-cell immunotherapies
generatorPowered by Slider Revolution 5.4.8 - responsive, Mobile-Friendly Slider Plugin for WordPress with comfortable drag and drop interface.
langen-us
twitter:cardsummary
twitter:titleDeveloping oral T-cell immunotherapies against cancer
twitter:descriptionVAXIMM is developing oral T-cell immunotherapies
twitter:image/wp-content/uploads/2016/07/openGraph-1.png
og:titleDeveloping oral T-cell immunotherapies against cancer
og:typewebsite
og:urlhttps://vaximm.com
og:image/wp-content/uploads/2016/07/openGraph-1.png
og:image:width1200
og:image:height628
og:site_nameVAXIMM
og:descriptionVAXIMM is developing oral T-cell immunotherapies
og:image:secure_url/wp-content/uploads/2016/07/openGraph-1.png
charsetutf-8

Test up to 1.000 webpages of vaximm.com with our free plan!

Try For Free
No trial. It's just free!

Page quality

Content
(Critically important)
There are only 439 words on this page. Good pages should have about 800 words of useful content.
There are 2 text duplicates on this page:
  • Duplicate: This website uses cookies to improve your experience while you navigat...
45.3% of the text are stop words.
Keywords used in the page title are also used in the page content. That's good!
The page contains a listing, which indicates a good text layout.
5 paragraphs were found on this page.
No placeholders texts or images were found.
The average number of words per sentence of 15.95 words is good.
Frames
(Critically important)
This page does not use a frameset.
Mobile optimization
(Somewhat important)
The file size of the HTML document is very large (649.9 kB).
A viewport "width=device-width, initial-scale=1.0" is provided.
At least one Apple touch icon is specified.
Bold and strong tags
(Somewhat important)
The usage of strong and bold tags is perfect. We recommend the use of up to 9 tags for this page.
Image SEO
(Somewhat important)
Alt text (alternative text) is correctly used on all found images.
Social Networks
(Nice to have)
This page is optimized perfectly for social networks.
Additional markup
(Nice to have)
No additional page markup was found.
HTTPS
(Somewhat important)
This website uses HTTPS to protect privacy and integrity of the exchanged data.
All included files are also transferred via HTTPS.

Media list

URLAlt attributeTitle
...tent/uploads/2016/07/vaximm_logo_pos.pngside-area-logo
...ds/2016/07/vaximm_logo_neg-tr-165x26.pngVAXIMM
...ds/2016/07/vaximm_logo_neg-tr-165x26.pngVAXIMM
...tent/uploads/2016/07/vaximm_logo_neg.pnglogo
...epress-multilingual-cms/res/flags/en.pngenEnglish
...epress-multilingual-cms/res/flags/de.pngdeDeutsch
...sets/images/no_image_resized_675-450.jpgStatement on the shareholder change
...sets/images/no_image_resized_675-450.jpgNEC OncoImmunity Acquires VAXIMM’s Neoantigen Vaccine Development Assets
...sets/images/no_image_resized_675-450.jpgVAXIMM to Attend International Scientific and Industry Events
...ds/2016/07/vaximm_logo_neg-tr-165x26.pngVAXIMM
Video URLWidthHeight
...s/2021/06/1012621217-hd-1_compressed.mp4100%100%

Page structure

H1 heading
(Critically important)
There is no H1 heading specified.
Headings
(Important)
The structure of headings is missing one or more levels. Do not skip heading levels.

Heading structure

Heading levelContent
H2 Developing oral T-cell immunotherapies to treat cancer patients
H3 Latest Press Releases
H4 Privacy Overview
H5 VAXIMM is a privately held, clinical-stage biotech company developing innovative cancer treatments
Some anchor texts are used more than once.
There are 4 links with a trivial anchor text.
The number of internal links is ok.
None of the anchor texts is too long.
All internal links are not using dynamic parameters.
There are 19 external links on this page.

Found links on this page

LinkAttributesAnchor text
https://vaximm.com/IMG-ALT side-area-logo
https://www.linkedin.com/compa...New window External Subdomain A-TITLE LinkedIN
https://twitter.com/hashtag/va...New window External A-TITLE Twitter
https://vaximm.com/dfd.name© DynamicFrameworks
A-TITLE DFD
https://vaximm.com/IMG-ALT VAXIMM
https://vaximm.com/Text duplicate IMG-ALT VAXIMM
https://vaximm.com/Anchor No Text
https://vaximm.com/English
https://vaximm.com/de/German
https://vaximm.com/IMG-ALT logo
A-TITLE Home
https://vaximm.com/HOME
https://vaximm.com/about-us/ABOUT US
https://vaximm.com/about-us/Company Overview
https://vaximm.com/about-us/Management Team
https://vaximm.com/about-us/Board of Directors
/research-development/RESEARCH & DEVELOPMENT
/research-development/Technology
/research-development/Clinical Programs
/research-development/Preclinical Programs
/research-development/Publications
https://vaximm.com/partnering/PARTNERS
https://vaximm.com/news/NEWS & EVENTS
https://vaximm.com/news/News
https://vaximm.com/eventsEvents
https://vaximm.com/contact/CONTACT
https://vaximm.com/IMG-ALT en
https://vaximm.com/de/IMG-ALT de
https://vaximm.com/about-us/Trivial anchor text
MORE
/research-development/Text duplicate Trivial anchor text
MORE
/research-development/Text duplicate Trivial anchor text
MORE
https://vaximm.com/partneringText duplicate Trivial anchor text
MORE
/statement-shareholder-change/Statement on the shareholder change
A-TITLE Statement on the shareholder change
https://www.facebook.com/share...External Subdomain No Text
https://plus.google.com/share?...External Subdomain No Text
http://www.linkedin.com/shareA...External Subdomain No Text
http://pinterest.com/pin/creat...External No Text
https://twitter.com/intent/twe...External No Text
/pr-nec-neoantigen-assets/NEC OncoImmunity Acquires VAXIMM’s Neoantigen Vaccine Development Assets
A-TITLE NEC OncoImmunity Acquires VAXIMM’s Neoantigen Vaccine Development Assets
https://www.facebook.com/share...External Subdomain No Text
https://plus.google.com/share?...External Subdomain No Text
http://www.linkedin.com/shareA...External Subdomain No Text
http://pinterest.com/pin/creat...External No Text
https://twitter.com/intent/twe...External No Text
/upcomingconf2021-junejuly/VAXIMM to Attend International Scientific and Industry Events
A-TITLE VAXIMM to Attend International Scientific and Industry Events
https://www.facebook.com/share...External Subdomain No Text
https://plus.google.com/share?...External Subdomain No Text
http://www.linkedin.com/shareA...External Subdomain No Text
http://pinterest.com/pin/creat...External No Text
https://twitter.com/intent/twe...External No Text
https://www.linkedin.com/compa...New window External Subdomain Text duplicate A-TITLE LinkedIN
https://twitter.com/hashtag/va...New window External Text duplicate A-TITLE Twitter
/terms-of-use-and-privacy-policy/Terms of Use and Privacy Policy
https://vaximm.com/imprint/Imprint
https://vaximm.com/Text duplicate IMG-ALT VAXIMM
https://vaximm.com/Anchor No Text
/terms-of-use-and-privacy-policy/New window Further information

Server configuration

HTTP redirects
(Critically important)
This page redirects to "https://vaximm.com/"
HTTP header
(Important)
No X-Powered HTTP header is sent.
This page uses GZip for compressed data transmission.
Performance
(Somewhat important)
The page response time of 0.85 seconds is longer than the recommended limit of 0.4 seconds. A high response time unnecessarily slows down search engine crawling and results in bad user experience as well.
The file size of the HTML document is very large (650 kB).

HTTP Response Header

NameValue
content-typetext/html; charset=UTF-8
dateFri, 15 Nov 2024 22:40:48 GMT
serverApache
expiresThu, 19 Nov 1981 08:52:00 GMT
cache-controlno-store, no-cache, must-revalidate
pragmano-cache
link<https://vaximm.com/wp-json/>; rel="https://api.w.org/", <https://vaximm.com/>; rel=shortlink
set-cookie50 Characters
content-encodinggzip
statuscode200
http_versionHTTP/2

External factors

This website has excellent links from other websites.
This page has backlinks from 142 referring domains.
This page has 543 backlinks.
This page has backlinks from 86 different ip addresses.

Links from Wikipedia

No links from Wikipedia were found.

Robots.txt

User-agent: *
Disallow: /wp-admin/
Allow: /wp-admin/admin-ajax.php

Sitemap: https://vaximm.com/sitemap.xml

Similar sites

Search preview

vaximm.com
Developing oral T-cell immunotherapies against cancer
VAXIMM is developing oral T-cell immunotherapies

Most important keywords

Following keywords were found. You can check the keyword optimization of this page for each keyword.

KeywordResultRecheck
Developing66%Check
VAXIMM65%Check
Developing oral T-cell65%Check
oral62%Check
T-cell62%Check
immunotherapies62%Check
oral T-cell immunotherapies62%Check
cancer53%Check
Cancer Patients47%Check
Cancer Treatments47%Check
Show more keywords and terms

Test up to 1.000 webpages of vaximm.com with our free plan!

Try For Free
No trial. It's just free!

Cookie Policy

We use cookies to make our site work and also for analytics and advertising purposes. You can enable or disable optional cookies as desired. See the following links for more information.

Contact | Privacy

We need these so the site can function properly

So we can better understand how visitors use our website

So we can serve you tailored ads and promotions